The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma - The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028184

Enrollment

Registered

2017-07-15

Start date

2005-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

We invited patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Interventions

administration of GHRP-2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Exclusion criteria

Exclusion criteria: Allergy to GHRP-2

Design outcomes

Primary

Measure	Time frame
Serum TSH, GH and prolactin levels after administration of GHRP-2	—

Countries

Japan

Contacts

Public ContactKazunori Kageyama

Hirosaki University Graduate School of Medicine Depertment of Endocrinology and Metabolism

kageyama@hirosaki-u.ac.jp0172-39-5062

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026